An Open-label, Randomized, Single-dose, 4-way Crossover Study to Assess the Relative Bioavailability of Axelopran and Oxycodone Administered as a Fixed-Dose Combination and as Individual Components to Healthy Subjects with a Naltrexone Block Under Fasting Conditions
100 项与 Theravance Biopharma R&D, Inc. 相关的临床结果
0 项与 Theravance Biopharma R&D, Inc. 相关的专利(医药)
100 项与 Theravance Biopharma R&D, Inc. 相关的药物交易
100 项与 Theravance Biopharma R&D, Inc. 相关的转化医学